Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Signal Transduction Pathway
100%
NF-B
100%
IB-MECA
100%
Anti-inflammatory Effect
100%
A3 Adenosine Receptor
100%
Adjuvant Arthritis
100%
Lymph Node
50%
Peripheral Blood Mononuclear Cells
37%
Receptor Expression
37%
Synovia
37%
Molecular Mechanism
25%
Expression Level
25%
Clinical Score
25%
Pathology Report
25%
Apoptosis
12%
Signaling Pathway
12%
Deregulation
12%
Inhibitory Effect
12%
Adenosine
12%
Three-level
12%
Nave
12%
Receptor-mediated
12%
Decreased Expression
12%
Receptor-interacting Protein Kinase 1 (RIPK1)
12%
A3 Adenosine Receptor Agonist
12%
Tumor Necrosis Factor-α
12%
Inflammatory Cells
12%
Receptor Downregulation
12%
Immune Cells
12%
Caspase-3
12%
Protein Expression Level
12%
Protein Extract
12%
Orally Bioavailable
12%
Synthetic Agonists
12%
Receptor Status
12%
Immunology and Microbiology
Signal Transduction
100%
Antiinflammatory Activity
100%
Lymph Node
100%
Arthritis
100%
Peripheral Blood Mononuclear Cell
75%
Agonist
50%
Extract
25%
Inflammatory Cell
25%
Immunocompetent Cell
25%
Downregulation
25%
Tumor Necrosis Factor Alpha
25%
Receptor down Regulation
25%
Caspase
25%
Protein Expression Level
25%
Pharmacology, Toxicology and Pharmaceutical Science
Piclidenoson
100%
Adenosine A3 Receptor
100%
Antiinflammatory Activity
100%
Adjuvant-Induced Arthritis
100%
Adjuvant Arthritis
100%
Disease
28%
Receptor
28%
Adenosine
28%
Biological Marker
14%
Tumor Necrosis Factor
14%
Adenosine A3 Receptor Agonist
14%
Caspase 3
14%
Receptor Protein
14%
Biochemistry, Genetics and Molecular Biology
Signal Transduction
100%
Antiinflammatory Activity
100%
Adenosine A3 Receptor
100%
Peripheral Blood Mononuclear Cell
37%
Eicosanoid Receptor
12%
Extract
12%
Adenosine
12%
Downregulation
12%
Tumor Necrosis Factor
12%
Agonist
12%
Receptor down Regulation
12%
Immunocompetent Cell
12%
Caspase 3
12%
Protein Expression Level
12%
Tumor Necrosis Factor Alpha
12%
Adenosine Receptor Agonist
12%